Literature DB >> 17720849

Autoimmunity to deltaNp63alpha in chronic ulcerative stomatitis.

L W Solomon1, M E Neiders, M G Zwick, K L Kirkwood, V Kumar.   

Abstract

Chronic ulcerative stomatitis (CUS) is a recently described mucocutaneous condition in which patients experience chronic, painful, ulcerative lesions of the oral mucosa. CUS is diagnosed by immunofluorescence studies that demonstrate antinuclear antibodies. These autoantibodies are specific for a protein, deltaNp63alpha, which is normally expressed in basal cell nuclei of stratified squamous epithelia. The purpose of this study was to characterize the autoimmune response in CUS. Protein antigens were produced by in vitro transcription/translation of polymerase chain-reaction (PCR)-amplified cDNAs. We used immunoblotting and immunoprecipitation experiments with serum from CUS patients to examine the (1) antibody isotype, (2) immunogenic functional domains of the deltaNp63alpha antigen, and (3) cross-reactivity with homologous p53, p73, and p63 proteins. Results demonstrate CUS patient antibodies to deltaNp63alpha, and 52% of cases have circulating IgA isotype antibodies. The N-terminal and DNA-binding domains are the immunodominant regions, and antibody cross-reactivity with p53, p63, and p73 isoforms is limited.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720849     DOI: 10.1177/154405910708600904

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  2 in total

Review 1.  Seventeen New Cases of Chronic Ulcerative Stomatitis with Literature Review.

Authors:  Rekha Reddy; Sarah G Fitzpatrick; Indraneel Bhattacharyya; Donald M Cohen; Mohammed N Islam
Journal:  Head Neck Pathol       Date:  2018-10-29

2.  The 30th birthday of chronic ulcerative stomatitis: A systematic review.

Authors:  Astrid Herzum; Martina Burlando; Emanuele Cozzani; Aurora Parodi
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.